tiprankstipranks
Trending News
More News >
Advertisement

ABOT - ETF AI Analysis

Compare

Top Page

ABOT

Donoghue Forlines Innovation ETF (ABOT)

Rating:71Outperform
Price Target:
ABOT, the Donoghue Forlines Innovation ETF, earns a solid overall rating largely because many of its biggest positions—like Apple, Adobe, Nvidia, Broadcom, and Qualcomm—combine strong financial performance with positive growth drivers in areas such as AI, data centers, and digital services. These strengths are partly offset by holdings like AbbVie and Verisign, where high valuations, leverage, and bearish technical signals introduce more risk. The main risk factor for the fund is its heavy tilt toward innovative tech and related names, which can be more volatile and sensitive to shifts in market sentiment and growth expectations.
Positive Factors
Focused Innovation Theme
The fund concentrates on innovative companies in areas like technology and health care, aiming to benefit if these growth themes do well over time.
Sector Diversification Within Growth Areas
Holdings are spread across several growth-oriented sectors, which helps avoid relying on just one industry for returns.
Moderate Expense Ratio
The fund’s fee is moderate for an actively themed ETF, so costs are not excessively high relative to its specialized focus.
Negative Factors
Recent Weak Performance
The ETF has shown weak returns over the past month, three months, and year to date, which may concern investors looking for near-term strength.
Heavy Tilt Toward Technology
A large share of the portfolio is in technology stocks, making the fund sensitive to downturns in that sector.
Underperforming Top Holdings
Several of the largest positions, including well-known names like Apple, Nvidia, and Adobe, have recently lagged, weighing on the fund’s overall results.

ABOT vs. SPDR S&P 500 ETF (SPY)

ABOT Summary

The Donoghue Forlines Innovation ETF (ABOT) follows the FCF US Quality Innovation Index, focusing on innovative U.S. companies across the total stock market. It leans heavily toward technology, but also includes health care, communication services, and consumer companies. Well-known holdings include Nvidia and Apple, along with other major tech and health care names. Someone might invest in ABOT to seek long-term growth and diversification in innovative businesses while still spreading risk across many stocks. A key risk is that it is heavily tilted toward tech, so its price can swing sharply with changes in the technology sector and overall market.
How much will it cost me?The Donoghue Forlines Innovation ETF (ABOT) has an expense ratio of 0.39%, meaning you’ll pay $3.90 per year for every $1,000 invested. This is slightly higher than average because it is actively managed, focusing on innovative strategies and a diverse mix of companies across sectors. Active management typically involves more research and decision-making, which can lead to higher costs.
What would affect this ETF?The Donoghue Forlines Innovation ETF (ABOT) could benefit from continued advancements in technology and healthcare, as these sectors make up a significant portion of its holdings. However, rising interest rates or regulatory changes in the U.S., where the fund is heavily focused, could negatively impact growth-oriented companies like Apple and Nvidia. Economic conditions and shifts in consumer spending may also influence the performance of its consumer cyclical and communication services holdings.

ABOT Top 10 Holdings

This ETF leans heavily into U.S. innovation, with a clear tech tilt led by Nvidia and Apple, which together set much of the tone. Nvidia has been rising and remains the star of the AI show, while Apple looks steadier, regaining some footing after a mixed stretch. On the flip side, software giant Adobe and chipmaker Qualcomm have been lagging, acting like a bit of sand in the fund’s gears. Health care names such as Bristol-Myers Squibb and Amgen are quietly climbing, adding a defensive counterweight to the tech-heavy lineup.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Nvidia5.98%$259.14K$4.45T58.45%
76
Outperform
Apple5.33%$230.82K$3.75T21.98%
79
Outperform
Broadcom3.83%$166.00K$1.59T75.57%
76
Outperform
Bristol-Myers Squibb3.23%$139.87K$120.05B-2.21%
78
Outperform
AbbVie3.12%$135.24K$398.49B6.53%
66
Neutral
Airbnb2.96%$128.05K$77.73B6.97%
71
Outperform
Adobe2.59%$112.22K$110.74B-28.60%
80
Outperform
Verisign2.57%$111.26K$21.56B0.68%
62
Neutral
Autodesk2.46%$106.78K$52.73B1.20%
74
Outperform
Qualcomm2.41%$104.61K$139.94B-13.68%
80
Outperform

ABOT Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
35.99
Negative
100DMA
37.93
Negative
200DMA
38.37
Negative
Market Momentum
MACD
-0.33
Negative
RSI
38.69
Neutral
STOCH
16.85
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ABOT, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 34.56, equal to the 50-day MA of 35.99, and equal to the 200-day MA of 38.37, indicating a bearish trend. The MACD of -0.33 indicates Negative momentum. The RSI at 38.69 is Neutral, neither overbought nor oversold. The STOCH value of 16.85 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ABOT.

ABOT Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$4.26M0.39%
71
Outperform
$99.08M0.65%
71
Outperform
$96.86M0.89%
69
Neutral
$94.56M0.75%
69
Neutral
$93.99M0.76%
68
Neutral
$91.20M0.85%
71
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ABOT
Donoghue Forlines Innovation ETF
34.00
-0.76
-2.19%
YALL
God Bless America ETF
BAMD
Brookstone Dividend Stock ETF
SOVF
Sovereign's Capital Flourish Fund
BUZZ
VanEck Social Sentiment ETF
STNC
Stance Equity ESG Large Cap Core ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement